These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells. Sanosaka T, Okuno H, Mizota N, Andoh-Noda T, Sato M, Tomooka R, Banno S, Kohyama J, Okano H. Sci Rep; 2022 Dec 31; 12(1):22648. PubMed ID: 36587182 [Abstract] [Full Text] [Related]
4. Sema3a plays a role in the pathogenesis of CHARGE syndrome. Ufartes R, Schwenty-Lara J, Freese L, Neuhofer C, Möller J, Wehner P, van Ravenswaaij-Arts CMA, Wong MTY, Schanze I, Tzschach A, Bartsch O, Borchers A, Pauli S. Hum Mol Genet; 2018 Apr 15; 27(8):1343-1352. PubMed ID: 29432577 [Abstract] [Full Text] [Related]
5. CHARGE syndrome protein CHD7 regulates epigenomic activation of enhancers in granule cell precursors and gyrification of the cerebellum. Reddy NC, Majidi SP, Kong L, Nemera M, Ferguson CJ, Moore M, Goncalves TM, Liu HK, Fitzpatrick JAJ, Zhao G, Yamada T, Bonni A, Gabel HW. Nat Commun; 2021 Sep 29; 12(1):5702. PubMed ID: 34588434 [Abstract] [Full Text] [Related]
6. CHARGEd with neural crest defects. Pauli S, Bajpai R, Borchers A. Am J Med Genet C Semin Med Genet; 2017 Dec 29; 175(4):478-486. PubMed ID: 29082625 [Abstract] [Full Text] [Related]
7. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Schnetz MP, Bartels CF, Shastri K, Balasubramanian D, Zentner GE, Balaji R, Zhang X, Song L, Wang Z, Laframboise T, Crawford GE, Scacheri PC. Genome Res; 2009 Apr 29; 19(4):590-601. PubMed ID: 19251738 [Abstract] [Full Text] [Related]
8. Sema3E is required for migration of cranial neural crest cells in zebrafish: Implications for the pathogenesis of CHARGE syndrome. Liu ZZ, Guo J, Lu Y, Liu W, Fu X, Yao T, Zhou Y, Xu HA. Int J Exp Pathol; 2019 Aug 29; 100(4):234-243. PubMed ID: 31464029 [Abstract] [Full Text] [Related]
10. Knockdown of fbxl10/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome. Balow SA, Pierce LX, Zentner GE, Conrad PA, Davis S, Sabaawy HE, McDermott BM, Scacheri PC. Dev Biol; 2013 Oct 01; 382(1):57-69. PubMed ID: 23920116 [Abstract] [Full Text] [Related]
11. Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination. He D, Marie C, Zhao C, Kim B, Wang J, Deng Y, Clavairoly A, Frah M, Wang H, He X, Hmidan H, Jones BV, Witte D, Zalc B, Zhou X, Choo DI, Martin DM, Parras C, Lu QR. Nat Neurosci; 2016 May 01; 19(5):678-689. PubMed ID: 26928066 [Abstract] [Full Text] [Related]
13. Roles of chromatin remodelers in maintenance mechanisms of multipotency of mouse trunk neural crest cells in the formation of neural crest-derived stem cells. Fujita K, Ogawa R, Kawawaki S, Ito K. Mech Dev; 2014 Aug 01; 133():126-45. PubMed ID: 24836203 [Abstract] [Full Text] [Related]
15. CHD7 regulates cardiovascular development through ATP-dependent and -independent activities. Yan S, Thienthanasit R, Chen D, Engelen E, Brühl J, Crossman DK, Kesterson R, Wang Q, Bouazoune K, Jiao K. Proc Natl Acad Sci U S A; 2020 Nov 17; 117(46):28847-28858. PubMed ID: 33127760 [Abstract] [Full Text] [Related]
19. Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome. Basson MA, van Ravenswaaij-Arts C. Trends Genet; 2015 Oct 03; 31(10):600-611. PubMed ID: 26411921 [Abstract] [Full Text] [Related]
20. CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression. Stathopoulou A, Wang P, Thellier C, Kelly RG, Zheng D, Scambler PJ. Cardiovasc Res; 2023 Sep 05; 119(11):2089-2105. PubMed ID: 37052590 [Abstract] [Full Text] [Related] Page: [Next] [New Search]